Diagnostic Models and Biomarker Evaluation in COVID-19

The COVID-19 pandemic has driven extensive efforts to develop rapid, accurate diagnostic tools that complement standard virological assays. Research has explored the integration of machine learning algorithms with routine clinical and laboratory data to create decision-support systems capable of screening, triaging and prognosticating patients. Biomarker evaluation has ranged from basic haematological parameters to multi-omics signatures, each offering distinct insights into host response and disease trajectory. Models based on statistical learning and artificial intelligence have demonstrated high discriminatory power, often rivalling or augmenting reverse transcription polymerase chain reaction (RT-PCR) in sensitivity and specificity. Practical implementations span emergency-department triage, point-of-care testing and resource-allocation scenarios, underscoring the global significance of data-driven approaches in managing clinical workload and reducing diagnostic delays.

Research from Nature Portfolio

A large-scale study constructed and cross-validated a diagnostic algorithm using routine blood tests from over 5 400 patients, including diverse bacterial and viral controls. By employing a gradient-boosting framework, the model achieved an area under the receiver operating characteristic curve of 0.97, with sensitivity above 80% and specificity near 98% at an optimised operating point. Key predictors comprised mean corpuscular haemoglobin concentration, eosinophil count, albumin level, international normalised ratio and prothrombin activity. Visualisation of high-dimensional data revealed that severe COVID-19 cases shared closer blood-profile characteristics with bacterial infections, suggesting pathways for complementary diagnostic strategies alongside RT-PCR and imaging.

Diagnostic Models and Biomarker Evaluation in COVID-19 publication trend

The graph below shows the total number of articles in diagnostic models and biomarker evaluation in covid-19 across all publications each year (not limited to Nature Index journals).

Technical terms

Biomarker: A measurable indicator of a biological state or pathological process, used here to denote blood-derived molecules or cells predictive of COVID-19 infection or severity.

Omics: Comprehensive analyses of molecular classes, including genomics, proteomics and metabolomics, that capture multi-layered host responses to infection.

Area under the receiver operating characteristic curve (AUC): A performance metric for classifiers that quantifies the trade-off between sensitivity and specificity across thresholds.

XGBoost: An optimized gradient-boosting algorithm that builds an ensemble of decision trees to improve predictive accuracy and control overfitting.

t-SNE (t-distributed stochastic neighbour embedding): A dimensionality-reduction technique that visualises high-dimensional data by preserving local structure in two or three dimensions.

Artificial neural network (ANN): A computational model inspired by biological neural networks, consisting of interconnected nodes (neurons) that learn patterns through weighted connections.

References

1. Evaluating Three Machine Learning Classification Methods for Effective COVID-19 Diagnosis. International Journal of Mathematics Statistics and Computer Science (2023).
2. Artificial intelligence for diagnosis of mild–moderate COVID-19 using haematological markers. Annals of Medicine (2023).
3. Machine learning to analyse omic-data for COVID-19 diagnosis and prognosis. BMC Bioinformatics (2023).
4. COVID-19 diagnosis by routine blood tests using machine learning. Scientific Reports (2021).